The evolution of personalized healthcare and the pivotal role of European regions in its implementation

C Nardini, V Osmani, PG Cormio, A Frosini… - Personalized …, 2021 - Taylor & Francis
C Nardini, V Osmani, PG Cormio, A Frosini, M Turrini, C Lionis, T Neumuth, W Ballensiefen…
Personalized medicine, 2021Taylor & Francis
Personalized medicine (PM) moves at the same pace of data and technology and calls for
important changes in healthcare. New players are participating, providing impulse to PM.
We review the conceptual foundations for PM and personalized healthcare and their
evolution through scientific publications where a clear definition and the features of the
different formulations are identifiable. We then examined PM policy documents of the
International Consortium for Personalised Medicine and related initiatives to understand …
Personalized medicine (PM) moves at the same pace of data and technology and calls for important changes in healthcare. New players are participating, providing impulse to PM. We review the conceptual foundations for PM and personalized healthcare and their evolution through scientific publications where a clear definition and the features of the different formulations are identifiable. We then examined PM policy documents of the International Consortium for Personalised Medicine and related initiatives to understand how PM stakeholders have been changing. Regional authorities and stakeholders have joined the race to deliver personalized care and are driving toward what could be termed as the next personalized healthcare. Their role as a key stakeholder in PM is expected to be pivotal.
Taylor & Francis Online
以上显示的是最相近的搜索结果。 查看全部搜索结果